PHLPP Sensitizes Multiple Myeloma Cells to Bortezomib Through Regulating LAMP2

Overview of attention for article published in OncoTargets and therapy, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 1 news story.

Jared Kaltwasser Primary and acquired resistance to bortezomib can increase recurrence rates in patients with multiple myeloma.